Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men

ClinicalTrials.gov ID: NCT04467697

Public ClinicalTrials.gov record NCT04467697. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:31 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6 Month, Open Label, Ambulatory Blood Pressure Monitoring (ABPM) Extension Study

Study identification

NCT ID
NCT04467697
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Marius Pharmaceuticals
Industry
Enrollment
155 participants

Conditions and interventions

Interventions

  • SOV2012-F1 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 17, 2018
Primary completion
Apr 30, 2020
Completion
Apr 30, 2020
Last update posted
Jun 27, 2024

2018 – 2020

United States locations

U.S. sites
19
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Alabama Clinical Therapeutics, LLC Birmingham Alabama 35235
Coastal Clinic Research Inc Mobile Alabama 36608
South Florida Medical Research Aventura Florida 33180
PAB Clinical Research Brandon Florida 33511
Jacksonville Impotence Treatment Center Jacksonville Florida 32223
My Community Research Center Miami Florida 33155
Oviedo Medical Research, LLC Oviedo Florida 32765
Meridien Research St. Petersburg Florida 33709
Northwest Clinical Trials Boise Idaho 83704
Centex Studies, Inc. Lake Charles Louisiana 70601
Quality Clinical Research, Inc. Omaha Nebraska 68114
Palm Research Center, Inc. Las Vegas Nevada 89148
Accumed Research Associates Garden City New York 11530
Manhattan Medical Research Practice, PLLC New York New York 10016
Rapha Institute for Clinical Research Fayetteville North Carolina 28314
Urologic Consultant of SE Pennyslvania Bala-Cynwyd Pennsylvania 19004
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464
University Diabetes Endocrine Consultants Chattanooga Tennessee 37411
Centex Studies, Inc. Houston Texas 77058

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04467697, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 27, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04467697 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →